scholarly article | Q13442814 |
P2093 | author name string | Patrick Sheahan | |
P2860 | cites work | Prognostic value of vocal cord fixation with respect to treatment in cancers of the supraglottis and pyriform sinus | Q30463266 |
Management of cancer of the supraglottis | Q30656383 | ||
The role of laser microsurgery in the treatment of laryngeal cancer | Q33281342 | ||
Transoral laser microsurgery for advanced laryngeal cancer | Q33310789 | ||
Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation | Q33383864 | ||
Multivariable analysis of risk factors for enlargement of the tracheoesophageal puncture after total laryngectomy | Q33576976 | ||
Patterns of nodal metastasis and surgical management of the neck in supraglottic laryngeal carcinoma | Q33675556 | ||
Laser surgery for early to moderately advanced glottic, supraglottic, and hypopharyngeal cancers. | Q33875427 | ||
Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer | Q34106818 | ||
Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study | Q34177388 | ||
Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience | Q34325002 | ||
Oncologic and functional outcomes of partial laryngeal surgery for intermediate-stage laryngeal cancer. | Q34468516 | ||
Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - results of 391 patients | Q34747274 | ||
Endoscopic supraglottic laryngectomy with postoperative irradiation | Q35680105 | ||
Factors influencing tumour relapse after total laryngectomy | Q36184618 | ||
Elective neck dissection during salvage laryngectomy | Q36308426 | ||
Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. | Q36583410 | ||
The pectoralis myofascial flap in pharyngolaryngeal surgery after radiotherapy. | Q51459670 | ||
Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer | Q57563501 | ||
The role of pectoralis major myofascial flap in salvage laryngectomy: A single surgeon experience | Q58083249 | ||
Legume intake and the risk of cancer: a multisite case–control study in Uruguay | Q59371655 | ||
Prognostic factors in T3,N0-1 glottic and transglottic carcinoma. A multifactorial study of 221 cases treated by surgery or radiotherapy | Q70882412 | ||
Complications of postoperative radiation therapy after partial laryngectomy in supraglottic cancer: A long-term evaluation | Q73740562 | ||
T3 glottic cancer: oncologic results and prognostic factors | Q73836909 | ||
The role of postradiotherapy neck dissection in supraglottic carcinoma | Q73941805 | ||
Randomized trial of induction chemotherapy in larynx carcinoma | Q74841143 | ||
Management of the N0 neck during salvage laryngectomy | Q77900480 | ||
Routine inclusion of level IV in neck dissection for squamous cell carcinoma of the larynx: is it justified? | Q79846357 | ||
Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma | Q80168624 | ||
N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02 | Q80735772 | ||
Functional and oncologic results of extended supracricoid partial laryngectomy | Q82624143 | ||
Planned neck dissection before combined chemoradiation in organ preservation protocol for N2-N3 of supraglottic or hypopharyngeal carcinoma | Q83427369 | ||
Predictors of outcome for advanced-stage supraglottic laryngeal cancer | Q83756773 | ||
The role of pectoralis major muscle flap in salvage total laryngectomy | Q84749562 | ||
Aspiration after supracricoid partial laryngectomy: Incidence, risk factors, management, and outcomes | Q84801758 | ||
Results of vocal rehabilitation using tracheoesophageal voice prosthesis after total laryngectomy and their predictive factors | Q84850151 | ||
Pharyngoesophageal stricture after treatment for head and neck cancer | Q85002901 | ||
Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer | Q36604903 | ||
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer | Q36625201 | ||
Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis | Q37014825 | ||
Selective neck dissection (IIA, III): a rational replacement for complete functional neck dissection in patients with N0 supraglottic and glottic squamous carcinoma | Q37053526 | ||
Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer | Q37289236 | ||
Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion | Q37338154 | ||
Elective neck dissection during salvage surgery for locally recurrent head and neck squamous cell carcinoma after radiotherapy with elective nodal irradiation | Q37737672 | ||
Paratracheal lymph node dissection in cancer of the larynx, hypopharynx, and cervical esophagus: the need for guidelines | Q37774977 | ||
The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease | Q37959114 | ||
Occupational exposures and cancer of the larynx-systematic review and meta-analysis | Q37967015 | ||
Supracricoid partial laryngectomy: analyses of oncologic and functional outcomes | Q38034052 | ||
Factors associated with supracricoid laryngectomy functional outcomes | Q38049497 | ||
Patterns of cervical node metastases from squamous carcinoma of the larynx | Q38061643 | ||
Impact of pharyngeal closure technique on fistula after salvage laryngectomy. | Q38098130 | ||
Pharyngocutaneous fistula after salvage laryngectomy: impact of interval between radiotherapy and surgery, and performance of bilateral neck dissection | Q38099810 | ||
Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer | Q38149063 | ||
Oncologic outcomes of total laryngectomy: impact of margins and preoperative tracheostomy | Q38195573 | ||
Experience with supracricoid laryngectomy variants | Q39398656 | ||
Radiotherapy for the clinically negative neck in supraglottic laryngeal cancer | Q43564188 | ||
Supracricoid laryngectomy with cricohyoidoepiglottopexy (CHEP) in the management of laryngeal carcinoma: oncologic results. A 35-year experience. | Q43688556 | ||
Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94 | Q43775355 | ||
Progress against laryngeal cancer in The Netherlands between 1989 and 2010. | Q43871702 | ||
The role of elective neck dissection in patients undergoing salvage laryngectomy | Q44239791 | ||
Occupational asbestos exposure and risk of pleural mesothelioma, lung cancer, and laryngeal cancer in the prospective Netherlands cohort study | Q44457671 | ||
Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy | Q44533684 | ||
Micronutrients and laryngeal cancer risk in Italy and Switzerland: a case-control study | Q44566955 | ||
Occult contralateral nodal metastases in supraglottic laryngeal cancer crossing the midline | Q44641102 | ||
Speech rehabilitation during the first year after total laryngectomy | Q44658286 | ||
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer | Q44674194 | ||
Factors predictive of survival in advanced laryngeal cancer | Q44835834 | ||
Definitive radiotherapy for T3 squamous cell carcinoma of the glottic larynx | Q45054375 | ||
Management of the N0 neck in recurrent laryngeal squamous cell carcinoma | Q45134005 | ||
Post laryngectomy speech rehabilitation outcome in elderly patients. | Q45147341 | ||
Primary surgical treatment of T3 glottic carcinoma: long-term results and decision-making aspects | Q45256263 | ||
Meta-analysis of impaired vocal cord mobility as a prognostic factor in T2 glottic carcinoma | Q45718616 | ||
Consumption of alcohol and risk of cancer among men: a 30 year cohort study in Lithuania. | Q45755342 | ||
Family history of cancer and the risk of laryngeal cancer: a case-control study from Italy and Switzerland. | Q45960932 | ||
Does an apple a day keep the oncologist away? | Q46642945 | ||
Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome | Q46755300 | ||
Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm | Q46870110 | ||
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer | Q46932585 | ||
Cause-specific mortality in a Chinese chrysotile textile worker cohort. | Q51299048 | ||
Primary versus secondary tracheoesophageal puncture for speech rehabilitation in total laryngectomy: long-term results with indwelling voice prosthesis. | Q51398345 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | larynx | Q9637 |
P304 | page(s) | e0015 | |
P577 | publication date | 2014-04-28 | |
P1433 | published in | Rambam Maimonides Medical Journal | Q18209815 |
P1476 | title | Management of advanced laryngeal cancer | |
P478 | volume | 5 |
Q64069191 | Clinical effect of postoperative chemoradiotherapy in resected advanced laryngeal squamous cell carcinoma |
Q64998994 | Clinical, Histological and Immunohistochemical Evaluation of Larynx Cancer. |
Q50544464 | Effect of postoperative use of diclofenac on pharyngocutaneous fistula development after primary total laryngopharyngectomy: Results of a single-center retrospective study. |
Q38485149 | Effectiveness of chemotherapy and radiotherapy for laryngeal preservation in advanced laryngeal cancer: a meta-analysis and systematic review |
Q48089400 | Evaluation of treatment outcomes in patients with supraglottic laryngeal cancer in Ontario, Canada: A population-based study |
Q92783925 | Long noncoding RNA FOXD2-AS1 enhances chemotherapeutic resistance of laryngeal squamous cell carcinoma via STAT3 activation |
Q55455714 | Online dosimetric evaluation of larynx SBRT: A pilot study to assess the necessity of adaptive replanning. |
Q26798220 | Understanding Complete Pathologic Response in Oesophageal Cancer: Implications for Management and Survival |